Introduction
The global rise of multidrug-resistant (MDR) bacteria presents a significant challenge to public health, often exacerbated by the intensive use of antibiotics in livestock. Florfenicol, a broad-spectrum antibiotic reserved for veterinary use, has seen increasing resistance among bacterial populations. One such opportunistic pathogen is Providencia rettgeri, known to cause urinary tract infections and other clinical complications. While the floR gene is a well-known mediator of florfenicol resistance via efflux pumps, the genomic configurations that enable extreme resistance levels are less understood. This study investigates a specific P. rettgeri isolate, R39, which exhibits unusually high resistance through a novel genetic mechanism: a tandem-repeat plasmid.
Methods
Researchers evaluated 45 Providencia isolates from diverse sources: human clinical samples (n=13), domestic animals (n=10), and freshwater fish (n=22). The study employed a multi-faceted approach:
- Antimicrobial Susceptibility Testing: Minimum Inhibitory Concentrations (MICs) were determined to quantify resistance levels.
- Molecular Screening: PCR was used to detect seven specific florfenicol resistance genes.
- Genomic Sequencing: A hybrid approach using Illumina (short-read) and PacBio (long-read) sequencing was utilized to resolve complex, repetitive genetic structures.
- Plasmid Characterization: S1-PFGE and plasmid curing experiments were conducted to confirm the link between specific plasmids and the observed resistance phenotypes.
Results and Genomic Architecture
The screening revealed that while human pathogens had a broader resistance spectrum, animal-derived isolates generally displayed higher MIC values. The floR gene was the only florfenicol resistance marker identified, present in 50% of animal isolates and 23.1% of human isolates, but absent in fish samples.
The R39 strain, isolated from a rabbit, showed an exceptionally high MIC for florfenicol (>512 mg/L). Genomic analysis revealed that R39 carries four plasmids. Most notably, the largest plasmid, pR39-33 (32,936 bp), contains four identical copies of a smaller 8,234 bp sequence (pR39-8) arranged in a tandem repeat. Each repeat unit carries a copy of the floR gene along with mobilization genes (mobAC).
Plasmid curing experiments confirmed the functional significance of these structures; losing the plasmids resulted in a 128-fold decrease in the florfenicol MIC (dropping to 4 mg/L).
Discussion: The Power of Gene Dosage
The discovery of pR39-33 highlights a "dosage compensation" strategy. By maintaining multiple copies of the floR gene on a single plasmid, the bacteria can significantly increase the production of efflux pumps, allowing them to survive antibiotic concentrations far exceeding standard resistance thresholds.
The presence of floR near insertion sequence remnants (IS91) suggests that these resistance modules are highly mobile. The tandem repeat structure likely formed through a recombination event, potentially mediated by these mobile elements. This architectural complexity allows for rapid adaptation to high antibiotic pressure in agricultural environments.
Conclusion
This study provides the first description of an antibiotic-resistant plasmid composed of four copies of another plasmid sequence in a tandem repeat. This mechanism of gene amplification represents a sophisticated evolutionary response to veterinary antibiotic use. Understanding these complex genomic structures is vital for monitoring the spread of high-level resistance from animal reservoirs to human clinical settings.
Summary updated